Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes-Reference-Cited by-同舟云学术

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes

Published:2000-08 Issue:8 Volume:28 Page:941-949
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Novitzky Nicolas,Mohamed Regana,Finlayson Jill,du Toit Cecile

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference35 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

2. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

3. In vitro studies of erythropoietin dependent regulation of erythropoiesis in myelodysplastic syndromes;Merchav;Leukaemia,1990

4. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors;Merchav;Leukemia,1991

5. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin in vitro, in aplastic anemia and myelodysplastic syndrome;Aoki;Am J Hematol,1990

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clonogenic potential of selected CD34+ cells from patients with MDS appear preserved when tested ex vivo;Leukemia Research;2011-09

2. Increased Apoptosis as a Mechanism of Ineffective Erythropoiesis in Myelodysplastic Syndromes;Clinical Leukemia;2008-05

3. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia;Bone Marrow Transplantation;2007-11-12

4. Impairment in immuno-modulatory function of Flk1+CD31−CD34− MSCs from MDS-RA patients;Leukemia Research;2007-11

5. Immunomodulatory Activities of Fluoroquinolones;Infection;2005-12